skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Refined by: language: Japanese remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
Material Type:
Article
Add to My Research

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

The Lancet (British edition), 2011-08, Vol.378 (9792), p.676-683 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 20-Aug 26, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61126-4 ;PMID: 21856481 ;CODEN: LANCAO

Full text available

2
Type 2 Diabetes Mellitus and Heart Failure: Innovative Possibilities for Management of Prognosis
Material Type:
Article
Add to My Research

Type 2 Diabetes Mellitus and Heart Failure: Innovative Possibilities for Management of Prognosis

Kardiologiia, , Vol.59 (4), p.76 [Peer Reviewed Journal]

ISSN: 0022-9040 ;DOI: 10.18087/cardio.2019.4.10253 ;PMID: 31002044

Digital Resources/Online E-Resources

3
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)
Material Type:
Article
Add to My Research

Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)

The American heart journal, 2010-07, Vol.160 (1), p.145-151 [Peer Reviewed Journal]

Mosby, Inc. ;2010 Mosby, Inc. ;2015 INIST-CNRS ;Copyright (c) 2010 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Jul 2010 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2010.02.037 ;PMID: 20598985 ;CODEN: AHJOA2

Full text available

4
Processing of Pro-Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site
Material Type:
Article
Add to My Research

Processing of Pro-Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site

Clinical chemistry (Baltimore, Md.), 2009-03, Vol.55 (3), p.489-498 [Peer Reviewed Journal]

2009 INIST-CNRS ;Copyright American Association for Clinical Chemistry Mar 2009 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2008.113373 ;PMID: 19168558 ;CODEN: CLCHAU

Full text available

5
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Material Type:
Article
Add to My Research

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1809-1815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.114264 ;PMID: 20551155 ;CODEN: ARDIAO

Full text available

6
The role of subclinical inflammation in progression of multifocal atherosclerosis during one year after myocardial infarction
Material Type:
Article
Add to My Research

The role of subclinical inflammation in progression of multifocal atherosclerosis during one year after myocardial infarction

Kardiologiia, 2014-01, Vol.54 (8), p.19 [Peer Reviewed Journal]

ISSN: 0022-9040 ;DOI: 10.18565/cardio.2014.8.19-25 ;PMID: 25464606

Digital Resources/Online E-Resources

7
Alterations in myocardial cytoskeletal and regulatory protein expression following a single Doxorubicin injection
Material Type:
Article
Add to My Research

Alterations in myocardial cytoskeletal and regulatory protein expression following a single Doxorubicin injection

Journal of cardiovascular pharmacology, 2003-05, Vol.41 (5), p.788 [Peer Reviewed Journal]

ISSN: 0160-2446 ;EISSN: 1533-4023 ;DOI: 10.1097/00005344-200305000-00017 ;PMID: 12717111

Digital Resources/Online E-Resources

8
Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks
Material Type:
Article
Add to My Research

Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks

Environmental health perspectives, 2012-11, Vol.120 (11), p.1503-1511 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2012 National Institute of Environmental Health Sciences ;COPYRIGHT 2012 National Institute of Environmental Health Sciences ;Copyright National Institute of Environmental Health Sciences Nov 2012 ;Distributed under a Creative Commons Attribution 4.0 International License ;2012 ;ISSN: 0091-6765 ;ISSN: 1552-9924 ;EISSN: 1552-9924 ;DOI: 10.1289/ehp.1204982 ;PMID: 22728254 ;CODEN: EVHPAZ

Full text available

9
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio
Material Type:
Article
Add to My Research

Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio

Biological psychiatry (1969), 2009-06, Vol.65 (11), p.979 [Peer Reviewed Journal]

EISSN: 1873-2402 ;DOI: 10.1016/j.biopsych.2009.01.032 ;PMID: 19344890

Digital Resources/Online E-Resources

10
A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ) Randomized Controlled Trial
Material Type:
Article
Add to My Research

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ) Randomized Controlled Trial

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1182-1192 [Peer Reviewed Journal]

2008 INIST-CNRS ;Copyright Nature Publishing Group May 2008 ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.1111/j.1572-0241.2007.01744.x ;PMID: 18371137

Full text available

11
Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer
Material Type:
Article
Add to My Research

Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer

European journal of cancer (1990), 2013-12, Vol.49 (18), p.3831 [Peer Reviewed Journal]

Copyright © 2013 Elsevier Ltd. All rights reserved. ;EISSN: 1879-0852 ;DOI: 10.1016/j.ejca.2013.08.002 ;PMID: 24007819

Digital Resources/Online E-Resources

12
Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
Material Type:
Article
Add to My Research

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation

Heart (British Cardiac Society), 1998-06, Vol.79 (6), p.568-575 [Peer Reviewed Journal]

1998 INIST-CNRS ;Copyright: 1998 British Cardiac Society ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/hrt.79.6.568 ;PMID: 10078083

Full text available

Searching Remote Databases, Please Wait